CCK2 receptor deficient mice: Changes in anxiety and pain sensitivity

被引:0
|
作者
Vasar, E
Koks, S
Abramov, U
Innos, J
Raud, S
Kurrikoff, K
Volke, V
Bourin, M
Matsui, T
机构
[1] Univ Tartu, Dept Physiol, Tartu, Estonia
[2] Univ Nantes, Dept Pharmacol, Nantes, France
[3] Kobe Univ, Sch Med, Dept Internal Med 3, Kobe, Hyogo 650, Japan
关键词
D O I
10.1016/S0924-977X(03)92190-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S384 / S384
页数:1
相关论文
共 50 条
  • [31] Acquisition of analgesic properties by the cholecystokinin (CCK)/CCK2 receptor system within the amygdala in a persistent inflammatory pain condition
    Roca-Lapirot, Olivier
    Fossat, Pascal
    Ma, Sherie
    Egron, Karine
    Trigilio, Gabriella
    Lopez-Gonzalez, Maria-Jose
    Covita, Joao
    Bouali-Benazzouz, Rabia
    Favereaux, Alexandre
    Gundlach, Andrew L.
    Landry, Marc
    PAIN, 2019, 160 (02) : 345 - 357
  • [32] CCK2 receptor as a therapeutic target for neuroendocrine tumours
    Stubbs, M
    Khan, K
    Savage, K
    McStay, M
    Dhillon, AP
    Caplin, ME
    GUT, 2003, 52 : A29 - A30
  • [33] Very low levels of cholecystokinin octapeptide activate Na-pump in the cerebral cortex of CCK2 receptor-deficient mice
    Roots, Kristiina
    Kairane, Czeslava
    Salum, Tiit
    Koks, Sulev
    Karelson, Ello
    Vasar, Eero
    Zilmer, Mihkel
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2006, 24 (06) : 395 - 400
  • [34] Phenotypes of mice with invalidation of cholecystokinin (CCK1 or CCK2) receptors
    Noble, F
    Roques, BP
    NEUROPEPTIDES, 2002, 36 (2-3) : 157 - 170
  • [35] Potential clinical indications for a CCK2 receptor antagonist
    Boyce, Malcolm
    Lloyd, Katie A.
    Pritchard, D. Mark
    CURRENT OPINION IN PHARMACOLOGY, 2016, 31 : 68 - 75
  • [36] Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice
    Sirli Raud
    Kertu Rünkorg
    Alar Veraksitš
    Ain Reimets
    Aleksei Nelovkov
    Urho Abramov
    Toshimitsu Matsui
    Michel Bourin
    Vallo Volke
    Sulev Kõks
    Eero Vasar
    Psychopharmacology, 2003, 168 : 417 - 425
  • [37] Targeted mutation of CCK2 receptor gene modifies the behavioural effects of diazepam in female mice
    Raud, S
    Rünkorg, K
    Veraksits, A
    Reimets, A
    Nelovkov, A
    Abramov, U
    Matsui, T
    Bourin, M
    Volke, V
    Koks, S
    Vasar, E
    PSYCHOPHARMACOLOGY, 2003, 168 (04) : 417 - 425
  • [38] Differences in behavioural effects of amphetamine and dopamine-related gene expression in wild-type and homozygous CCK2 receptor deficient mice
    Runkorg, Kertu
    Varv, Siim
    Matsui, Toshimitsu
    Koks, Sulev
    Vasar, Eero
    NEUROSCIENCE LETTERS, 2006, 406 (1-2) : 17 - 22
  • [39] Pharmacological analysis of CCK2 receptor ligands using COS-7 and SK-N-MC cells, expressing the human CCK2 receptor
    Nilsson, I
    Monstein, HJ
    Lindström, E
    Håkanson, R
    Svensson, S
    REGULATORY PEPTIDES, 2002, 103 (01) : 29 - 37
  • [40] The conformation required for the binding of gastrin to the human CCK2 receptor
    Ahmed, S
    Copps, J
    Babin, D
    Lovas, S
    Murphy, RF
    REGULATORY PEPTIDES, 2004, 122 (01) : 33 - 33